Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) TherapySepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2021
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal MetastasesInna Smalley, Zhihua Chen, Manali Phadke, et al.
Neuro-Oncology|February 25, 2022
A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanomaVincent Law, Zhihua Chen, Francesca Vena, et al.
BMC Cancer|May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastasesMatthew N Mills, Afrin Naz, Chetna Thawani, et al.
Neuro-Oncology|April 16, 2013
Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycinFranz J Zemp, Xueqing Lun, Brienne A McKenzie, et al.
Cancer Immunology Research|November 17, 2021
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer VaccineAmrita Basu, Gabriella K Albert, Sabrina Awshah, et al.
Cancer Immunology Research|March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityManali S Phadke, Zhihua Chen, Jiannong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primatesWen Qing Yang, Xueqing Lun, Cheryl Ann Palmer, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2023
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastasesAmmoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, et al.
Breast Cancer Research and Treatment|October 20, 2021
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIsMatthew N Mills, Thrisha K Potluri, Yuki Kawahara, et al.
Pageof 11